Search Ontology:
ChEBI
nilotinib
- Term ID
- CHEBI:52172
- Synonyms
-
- 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide
- AMN 107
- AMN107
- nilotinib
- nilotinibum
- Definition
- References
-
- CAS:641571-10-0
- DrugBank:DB04868
- Drug_Central:1932
- KEGG:D08953
- LINCS:LSM-1099
- PDBeChem:NIL
- PMID:16775235
- PMID:17068153
- PMID:17090651
- PMID:17611564
- PMID:17720881
- PMID:17958915
- PMID:17987222
- PMID:18191450
- PMID:18318563
- PMID:18326784
- PMID:18549348
- PMID:18922118
- PMID:18956997
- PMID:19188713
- PMID:19427995
- PMID:19449194
- PMID:19493708
- PMID:19519355
- PMID:19527930
- PMID:19652056
- PMID:27194024
- PMID:35333006
- PMID:39009709
- PMID:39267544
- PMID:39459541
- PMID:39634983
- PMID:39739907
- PMID:39887138
- PMID:39903581
- Wikipedia:Nilotinib
- Ontology
- ChEBI ( EBI )
- is a type of
- has_role
-
Phenotype
Phenotype resulting from nilotinib
Phenotype where environments contain nilotinib
Phenotype modified by environments containing nilotinib
Phenotype affecting nilotinib
Human Disease Model